Menu
Back to User profile » Dr Hitoshi Tabuchi
Papers published by Dr Hitoshi Tabuchi:
Comparison of visual performance of toric versus non-toric intraocular lenses with same material
Yamauchi T, Tabuchi H, Takase K, Ohara Z, Imamura H, Kiuchi Y
Clinical Ophthalmology 2018, 12:2237-2243
Published Date: 1 November 2018
The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study
Okumichi H, Kiuchi Y, Baba T, Kanamoto T, Naito T, Nakakura S, Tabuchi H, Nii H, Sueoka C, Sugimoto Y
Clinical Ophthalmology 2017, 11:1175-1181
Published Date: 21 June 2017
Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
Shimizu Y, Nakakura S, Nishiyama M, Tabuchi H, Kiuchi Y
Clinical Ophthalmology 2015, 9:475-482
Published Date: 12 March 2015
Prostaglandin-associated periorbitopathy in latanoprost users
Nakakura S, Yamamoto M, Terao E, Nagatomi N, Matsuo N, Fujisawa Y, Fujio Y, Tabuchi H, Kiuchi Y
Clinical Ophthalmology 2015, 9:51-56
Published Date: 30 December 2014
Case of cytomegalovirus retinitis aggravated by sub-Tenon injection of triamcinolone acetonide with subsequent metastatic liver cancer
Yamamoto Y, Kato Y, Tabuchi H, Fukushima A
Clinical Ophthalmology 2013, 7:411-415
Published Date: 1 March 2013
Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
Nakakura S, Tabuchi H, Baba Y, Maruiwa F, Ando N, Kanamoto T, Kiuchi Y
Clinical Ophthalmology 2012, 6:369-375
Published Date: 6 March 2012